- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/712 - Nucleic acids or oligonucleotides having modified sugars, i.e. other than ribose or 2'-deoxyribose
Patent holdings for IPC class A61K 31/712
Total number of patents in this class: 1978
10-year publication summary
|
101
|
104
|
121
|
157
|
149
|
153
|
197
|
187
|
162
|
153
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Ionis Pharmaceuticals, Inc. | 955 |
138 |
| Alnylam Pharmaceuticals, Inc. | 1178 |
50 |
| Wave Life Sciences Ltd. | 221 |
39 |
| Hoffmann-La Roche Inc. | 3783 |
32 |
| F. Hoffmann-La Roche AG | 7836 |
31 |
| Sarepta Therapeutics, Inc. | 387 |
27 |
| Nippon Shinyaku Co., Ltd. | 322 |
26 |
| University of Massachusetts | 2313 |
26 |
| Osaka University | 3269 |
24 |
| Avidity Biosciences, Inc. | 179 |
24 |
| Roche Innovation Center Copenhagen A/S | 128 |
20 |
| The Regents of the University of California | 20720 |
19 |
| Arrowhead Pharmaceuticals, Inc. | 347 |
17 |
| Empirico Inc. | 103 |
17 |
| Isis Pharmaceuticals, Inc. | 182 |
16 |
| National Center of Neurology and Psychiatry | 153 |
15 |
| Centre National de La Recherche Scientifique | 11016 |
14 |
| Dyne Therapeutics, Inc. | 259 |
14 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3337 |
12 |
| Sirnaomics, Inc. | 110 |
12 |
| Other owners | 1405 |